# PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril

> **NCT04656847** · — · COMPLETED · sponsor: **Servier Russia** · enrollment: 504 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Infarction
- Arterial Hypertension

## Interventions

- **DRUG:** in daily everyday routine practice

## Key facts

- **NCT ID:** NCT04656847
- **Lead sponsor:** Servier Russia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2021-10-05
- **Final completion:** 2021-10-18
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04656847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04656847, "PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04656847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*